Key points are not available for this paper at this time.
Patients on average can expect a loss of 7% of midfacial volume/10 kg of total weight loss, primarily in superficial fat pads. This represents one of the first quantitative assessment of the "Ozempic face" phenomenon.
Sharma et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: